Human recombinant granulocyte-macrophage colony stimulating factor (hrGM-CSF) improves double hemibody irradiation (DHBI) tolerance in patients with stage III multiple myeloma: A pilot study

MLA

Xavier Troussard, et al. “Human Recombinant Granulocyte-Macrophage Colony Stimulating Factor (HrGM-CSF) Improves Double Hemibody Irradiation (DHBI) Tolerance in Patients with Stage III Multiple Myeloma: A Pilot Study.” British Journal of Haematology, vol. 89, Jan. 1995, pp. 191–95. EBSCOhost, https://doi.org/10.1111/j.1365-2141.1995.tb08929.x.

APA

Xavier Troussard, I. Tabah, A. Batho, Margaret Macro, Michel Leporrier, A. M. Peny, Oumedaly Reman, & B. Vie. (1995). Human recombinant granulocyte-macrophage colony stimulating factor (hrGM-CSF) improves double hemibody irradiation (DHBI) tolerance in patients with stage III multiple myeloma: A pilot study. British Journal of Haematology, 89, 191–195. https://doi.org/10.1111/j.1365-2141.1995.tb08929.x

Chicago

Xavier Troussard, I. Tabah, A. Batho, Margaret Macro, Michel Leporrier, A. M. Peny, Oumedaly Reman, and B. Vie. 1995. “Human Recombinant Granulocyte-Macrophage Colony Stimulating Factor (HrGM-CSF) Improves Double Hemibody Irradiation (DHBI) Tolerance in Patients with Stage III Multiple Myeloma: A Pilot Study.” British Journal of Haematology 89 (January): 191–95. doi:10.1111/j.1365-2141.1995.tb08929.x.